COVID-19 vaccine from this quarter, it told Reuters, which would be earlier than an “end of this year” forecast by the Indian company.GAVI co-leads the COVAX facility for equitable distribution of COVID-19 shots around the world.
COVAX suffered a big jolt in April when big vaccine producer India stopped all overseas shipments to meet local demand as infections rose dramatically.India’s coronavirus crisis has now eased and output of the AstraZeneca drug at SII, the world’s biggest vaccine maker, has also jumped, but so has domestic demand.